Minimal Hepatic Encephalopathy among Cirrhotics: A Cross Sectional, Clinico-Epidemiological, Multicentre, Nationwide Study: THE PREDICT STUDY - THE PREDICT STUDY

Abbott India Limited0 个研究点目标入组 1,260 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•1. Patients of either sex, 18-65 years of age, who have attended school at least till the 5th Class/Standard, having an established diagnosis of liver cirrhosis without any overt symptoms at time of testing with Grade 0 of West Haven criteria.
•2. Patients willing to undergo the neuropsychological (NP) tests and to complete the SF-36 questionnaire for the estimation of HRQOL.
•3. Patients willing to provide written authorization to provide data for the study.

•1. History of recent alcohol intake ( 12 weeks)/substance abuse , or gastrointestinal bleeding ( 4 weeks), serious infection, use of drugs affecting psychometric performances ( 4 weeks).
•2. Severe medical problems that could influence quality-of-life measurement
•3. Inability to perform neuropsychometric tests and to complete the SF-36 questionnaire.
•4. Patients with neuropsychiatric diseases like stroke, epilepsy, dementia, parkinsonism etc.
•5. Hepatocellular carcinoma

发起方